logo

This website uses cookies to ensure you get the best experience on our website.

Read through our Privacy Policy to learn more.

 Go Back

EyePoint Pharmaceuticals: Q4 Earnings Snapshot

By AP News - Mar 05, 2025, 07:34 AM ET
Last Updated - Mar 05, 2025, 07:34 AM EST
EyePoint Pharmaceuticals: Q4 Earnings Snapshot

WATERTOWN, Mass. (AP) — WATERTOWN, Mass. (AP) — EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $41.4 million in its fourth quarter.

On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of 64 cents.

Sponsored

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 41 cents per share.

The drug delivery technology company posted revenue of $11.6 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $14.7 million.

For the year, the company reported a loss of $130.9 million, or $2.32 per share. Revenue was reported as $43.3 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT

Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250415